Patent Regulation in the Field of Genome: Trends, Problems, Prospects

The paper examines the situation that has developed in recent years in the field of patenting the results of genomic and genetic research and manipulation, the main trends and possible ways of developing relations and regulation in this area. This includes the role of Russia and the BRICS countries in the future world order, where genetic and genomic technologies and the fruits of their application will (and partly are already) one of the most important values. The author analyzes the existing and possible forms of securing rights to these values for copyright holders, and accounts the difference between genetics and genomics (and the gradual erosion of this difference with the appearance of «designer genes»). The author concludes that now there is no sufficiently developed, reasonable and workable alternative to the existing system of protection of the rights to the achievements of genetics and genomics while maintaining the expediency of searching for such an alternative. The existing system provides unreasonably many advantages to individual corporations and states that have managed to secure the largest possible amount of rights to the achievements of genetics and genomics. The paper analyzes some international acts designed to ensure a fair distribution of benefits between the owners of advanced technologies and the «suppliers» of the original genetic material. These have so far been undeservedly ignored in our country, but are gaining new significance in the course of the ongoing «genomic revolution» based on the mass application of the CRISPR-Cas genomic editing method. Possible directions for coordinated actions of the BRICS countries on patent cooperation in relation to the results of genomic and genetic research and manipulation are proposed. As one of the conclusions, it is indicated that the use of BRICS as a platform for building a better future for all mankind, and not only for patent holders, fully corresponds to the role and prospects of BRICS in the modern international system, stated in the Concept of the Participation of the Russian Federation in the BRICS association.

1. Afanasev DV. O sootnoshenii izobreteniy, otkrytiy i abstraktnykh idey [On the relationship of inventions, discoveries and abstract ideas. Intellektualnaya sobstvennost. Promyshlennaya sobstvennost [Intellectual property. Industrial property]. 2019;1:13-20. (In Russ.).

2. Bogdanova EE. Pravovye problemy i riski geneticheskoy revolyutsii: geneticheskaya informatsiya i diskriminatsiya [Legal problems and risks of genetic revolution: Genetic information and discrimination]. Lex russica. 2019;6:18-29. (In Russ.).

3. Vorozhevich AS. Vtorichnye patenty na lekarstvennye preparaty: nuzhno li ogranichit ikh vydachu? [Secondary patents for medicinal products: is it necessary to restrict their issuance?]. Zakon [Law]. 2016;9:117-130. (In Russ.).

4. Ivanov AA. Ekonomicheskie osnovaniya veshchnykh prav [Economic grounds of property rights]. Zakon [Law]. 2015;12:141-149. (In Russ.).

5. Ivanov A. Dat znaniyam svobodu [To give freedom to knowledge]. Rossiya v globalnoy politike [Russia in global politics]. 2016;1. Available from: https://globalaffairs.ru/articles/dat-znaniyam-svobodu/ [cited 2020 April 06]. (In Russ.).

6. Ivanov AYu, Katalevskiy DYu, Lianos Ya. Rynok semyan: globalizatsiya, konkurentsiya i intellektualnaya sobstvennost [Seed market: Globalization, competition and intellectual property]. Zakon [Law]. 2016;5:49- 66. (In Russ.).

7. Ivanov AYu. Mify o legalnoy monopolii, ili skaz o tom, pochemu v Rossii ne razvivayutsya innovatsii pri upornoy okhrane intellektualnoy sobstvennosti [Myths about legal monopoly, or a fairy tale about why innovations are not developing in Russia with persistent protection of intellectual property]. Zakon [Law]. 2020;2:86-102. (In Russ.).

8. Kalinichenko PA. Razvitie sudebnoy praktiki po delam v sfere genomiki cheloveka: mirovoy opyt i Rossiya [Development of court practice in cases involving human genomics: world experience and Russia]. Lex russica. 2019;6:30-36. (In Russ.).

9. Kamyshanskiy VP, Stanishevskiy AI. Gennaya inzheneriya v grazhdanskom prave [Genetic engineering in civil law]. Vlast zakona [The Reign of Law]. 2018;4:33-44. (In Russ.).

10. Kiseleva AYu. Shrift kak obekt avtorskogo prava v Rossii i SShA [Font as an object of copyright in Russia and the USA]. Intellektualnaya sobstvennost. vtorskoe pravo i smezhnye prava [Intellectual property. Copyright and related rights]. 2015;5:25-32. (In Russ.).

11. Ksenofontova DS. Pravovye osnovy gennoy terapii: v poiskakh balansa interesov [Gene therapy legal framework: In search of balance of interests]. Lex russica. 2019;6:143-152. (In Russ.).

12. Redchikova NA, Chikov MV. Otsenka innovatsionnoy aktivnosti v stranakh BRIKS [Assessment of innovation activity in the BRICS countries]. Vestnik Tomskogo gosudarstvennogo universiteta [Tomsk State University Journal]. 2013;2(22):40-50. (In Russ.).

13. Sidorova EA. Innovatsionnoe razvitie stran BRIKS, predposylki i perspektivy sotrudnichestva [Innovative development of the BRICS countries, prerequisites and prospects for cooperation]. Vestnik mezhdunarodnykh organizatsiy [Bulletin of International Organizations]. 2018;13(1):34-50. (In Russ.).

14. Fomina OA. O vozmozhnosti sudebnoy zashchity pri redaktirovanii genoma cheloveka [Availability of judicial protection in the process of editing the human genome]. Lex russica. 2019;6:37-47. (In Russ.).

15. Churilov AYu. Problemy patentnoy okhrany biotekhnologicheskikh izobreteniy [Problems of patent protection of biotechnological inventions]. Intellektualnaya sobstvennost. Promyshlennaya sobstvennost [Intellectual property. Industrial property]. 2019;3:67-77. (In Russ.).

16. Gibson DG, Glass JI, Lartigue C, Noskov VN, Chuang RY, Algire MA, Benders GA, Montague MG, Ma L, Moodie MM, Merryman C, Vashee S, Krishnakumar R, Assad-Garcia N, Andrews-Pfannkoch C, Denisova EA, Young L, Zhi-Qing Qi, Segall-Shapiro TH, Calvey CH, Parmar PP, Hutchison CA III, Smith HO, Venter JC. Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome. Science. 2 Jul. 2010. 2010;329(5987):52-56. Available from: https://science.sciencemag.org/content/329/5987/52 [cited 2020 April 03].

17. Hutchison CA III, Chuang RY, Noskov VN, Assad-Garcia N, Deerinck TJ, Ellisman MH, Gill J, Kannan K, Karas BJ, Ma L, Pelletier JF, Zhi-Qing Qi, Richter RA, Strychalski EA, Sun L, Suzuki Y, Tsvetanova B, Wise KS, Smith HO, Glass JI, Merryman C, Gibson DG, Venter JC. Design and synthesis of a minimal bacterial genome. Science. 25 Mar. 2016. 2016;351(6280):aad6253. Available from: https://science.sciencemag.org/content/351/6280/aad6253 [cited 2020 April 03].

18. Khambhati K, Bhattacharjee G, Singh V. Current progress in CRISPR‐based diagnostic platforms. J Cell Biochem. 2019;120:2721‐2725. Available from: https://doi.org/10.1002/jcb.27690 [cited 2020 April 03].

19. May C, Sell S. Intellectual Property Rights: A Critical History. Lynne Rienner Publishers, Inc. 2006. Available from: https://www.rienner.com/title/Intellectual_Property_Rights_A_Critical_History.